China Pharma Holdings (CPHI) Other Accumulated Expenses (2019 - 2023)

China Pharma Holdings (CPHI) has reported Other Accumulated Expenses for 5 consecutive years, with $1.1 million the latest figure, recorded in Q4 2023.

• For the quarter ending Q4 2023, Other Accumulated Expenses fell 54.21% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2023 stood at $1.1 million (down 54.21% YoY), and the FY2023 full-year result was $1.1 million, down 54.21% from the prior year.
• Other Accumulated Expenses climbed to $1.1 million in Q4 2023 per CPHI's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.1 million in Q3 2021 and bottomed at $1.1 million in Q3 2023.
• Historically, Other Accumulated Expenses has averaged $2.3 million across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses jumped 30.23% in 2021, then tumbled 54.69% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $2.1 million in 2019, then climbed by 3.01% to $2.1 million in 2020, then surged by 30.23% to $2.8 million in 2021, then decreased by 10.93% to $2.5 million in 2022, then plunged by 54.21% to $1.1 million in 2023.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.1 million, $1.1 million, and $2.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.